Related Experiment Videos
Infantile hypertrophic pyloric stenosis after prenatal exposure to thalidomide
Insights
Thalidomide embryopathy (ThE) cases showed a significant increase in infantile hypertrophic pyloric stenosis (IHPS), suggesting thalidomide influences IHPS development, likely on a genetic predisposition.
Area of Science:
- Pediatric Surgery
- Teratology
- Gastroenterology
Background:
- Infantile hypertrophic pyloric stenosis (IHPS) is a common gastrointestinal malformation in infants.
- Thalidomide embryopathy (ThE) is a severe congenital disorder linked to thalidomide exposure during pregnancy.
- The etiology of IHPS is multifactorial, involving genetic and environmental factors.
Purpose of the Study:
- To investigate the association between thalidomide embryopathy and infantile hypertrophic pyloric stenosis.
- To determine if thalidomide exposure influences the manifestation of IHPS.
- To explore the role of genetic predisposition in thalidomide-induced IHPS.
Main Methods:
- Retrospective study of 832 thalidomide embryopathy cases (October 1959 - July 1962).
- Analysis of clinical course, radiographic and surgical findings, and sex ratio of IHPS cases within the ThE cohort.
- Comparison of IHPS characteristics in ThE cases with spontaneously occurring IHPS.
Main Results:
- A highly significant accumulation of IHPS cases was observed in infants with ThE.
- IHPS was the predominant gastrointestinal abnormality in ThE, ranking 3rd among inner organ defects.
- Clinical and demographic features of IHPS in ThE mirrored those of spontaneous IHPS, including male preponderance.
- Coincidental occurrence of IHPS with hiatus hernia and tracheo-oesophageal fistula was noted in ThE cases.
Conclusions:
- Thalidomide appears to influence the manifestation of IHPS, rather than being a sole cause.
- Genetic or familial predisposition is likely crucial for thalidomide to impact IHPS development.
- IHPS development is multifactorial, with polygenic inheritance patterns.
- Other teratogenic substances may potentially influence IHPS development similarly to thalidomide.
Abstract:
In a retrospective study of 832 cases of thalidomide embryopathy (ThE) between October 1, 1959 and July 31, 1962, a highly significant accumulation of cases with infantile hypertrophic pyloric stenosis (IHPS) was registrated. Clinical course, X-ray and surgical findings and the sex ratio (male preponderance) were identical to IHPS occurring spontaneously. In the order of frequency of defects in ThE, IHPS is on position 11; among inner organ abnormalities, IHPS is on position 3 after heart and kidney defects. Thus, IHPS is the predominant gastrointestinal abnormality in ThE. For the first time, a substance (thalidomide) could be identified which obviously is able to influence manifestation of IHPS. There is a remarkable coincidence of IHPS and malformations such as hiatus hernia and tracheo-oesophageal fistula with or without oesophagus atresia. From the male preponderance, which is also observed in the ThE type of IHPS, it is concluded that thalidomide is not a primary cause in this process, but that disease manifestation is decisively influenced by thalidomide on the base of a genetic or familiar predisposition. Cause and development of IHPS are multifactorial; the mode of inheritance is polygenic. Probably, other substances may replace thalidomide.